4 Contributing to a UK Innovation
Strategy
A strategic
approach to business-university collaboration
56. In January 2014, the Government produced the
following assessment of the strengths and weaknesses in the UK's
science and innovation system:[114]
Table 1: Analysis of main strengths and weaknesses
of UK science and innovation system, taken from BIS benchmarking
analysis.
This analysis found effective university collaboration
with R&D intensive businesses, but limited collaboration between
universities and SMEs more broadly. It concluded that "this
may explain some of the low levels of innovation among SMEs".[115]
Furthermore, it stated that this low level of innovation amongst
SMEs "is likely to be a significant drag on productivity".[116]
57. We recommend that the forthcoming Science
and Innovation Strategy address each key relative weakness of
the UK's innovation system, as outlined in the BIS Benchmarking
Analysis. The Strategy should identify and explain which Government
policies, programmes and incentives are designed to tackle those
weaknesses, and explain how the effectiveness of those interventions
will be measured, monitored and evaluated.
58. As the Government prepares its Science and
Innovation Strategy, there is a need for clarity on how its policies
will utilise the strengths of universities across Scotland, Northern
Ireland, Wales and England within a UK-wide strategy. Businesses
operate across the UK, so coordination with devolved administrations
is required to ensure coherence in the innovation support system.
Measuring success: the R&D
scoreboard
59. The R&D scoreboard was a BIS-produced annual
record of R&D spend in private companies. The scoreboard monitored
the 1,000 UK companies that invested most in R&D, and the
1,000 global companies that invested most in R&D, and compared
the two. Production of this document was discontinued in 2010.
Since then, there have been calls for its reintroduction, in order
to help monitor this field.[117]
60. The Minister told us that scrapping the scoreboard
had saved approximately £500,000 a year.[118]
He also said that statistics outlining R&D spend by the private
and public sectors in the UK were freely available from other
sources. The R&D scoreboard therefore "was not the only
statistical insight into research and development spending".
For that reason he argued that no one was "massively disadvantaged
by not having it".[119]
However, when he gave evidence, he was unable to set out clearly
the level of R&D spend.[120]
61. Many of the Government's major initiatives
are aimed at increasing R&D activity in the UK and encouraging
investment in a wide portfolio of sectors and technologies. It
is important that the Government has a respected and impartial
way to evaluate the success of such initiatives. This is particularly
significant at a time of constrained public spending.
62. We recommend that the Government reintroduce
a means of monitoring R&D activity, a function previously
fulfilled by the R&D scoreboard, in order to measure progress
in its R&D initiatives. Use of the scoreboard, or similar
indicators, should be built into mechanisms for measuring progress
in implementing the forthcoming Science and Innovation Strategy.
The structural gap in R&D
spend
63. According to the National Audit Office, R&D
is "historically the most cited metric of innovation in an
economy".[121]
Overall investment in R&D by government, industry and others
can be measured by considering total investment as a percentage
of GDP. This is known as the R&D intensity. Figure 2 gives
an international comparison of R&D intensity. In 2012, the
UK's gross domestic expenditure on research and development was
£27 billion, approximately 1.72 per cent of GDP. In contrast,
the US spends around £250bn (2.8 per cent of GDP) on R&D
per annum. France and Germany consistently invest more than 2
per cent of their GDP in R&D.[122]
Figure 2: International comparison of spending
on R&D as a percentage of GDP in 2011, taken from NAO analysis,
p39
64. This comparatively low position internationally
follows "a sustained period of national disinvestment in
R&D" in the UK.[123]
The Sheffield Political Economy Research Institute states:
In 1979 the UK was one of the most research-intensive
economies in the world. Now, amongst advanced industrial economies,
it is one of the least.[124]
UK spending as a percentage of GDP has therefore
been falling. [125]
This is at a time when many other countries have been increasing
their investment in this field. The EU Innovation Scorecard is
a comparative assessment of the innovation performance of EU Member
States. According to that Scorecard, the UK's performance is slipping:
from 5th position in 2010[126]
to 8th position in 2014.[127]
The UK's pattern of spending therefore contrasts to the growth
seen in R&D spend in other OECD and EU countries (Figure 3).[128]
Therefore, not only is the UK's investment in R&D relatively
low in international terms, it is also declining. [129]
Figure 3: R&D intensity of selected economies
over the period 1980-2011, expressed as Gross Expenditure on R&D
as a fraction of GDP. Source: Sheffield Political Economy Research
Institute

65. Will Hutton, Chair of the Big Innovation Centre,
told us that the UK has constructed a "medium-to-low R&D
intensity economy", which meant that "when you are trying
to leverage public expenditure, the counter parties for that are
harder to find".[130]
Professor Richard Jones, Pro-Vice Chancellor for Research and
Innovation at the University of Sheffield, also highlighted the
fact that the "weak link" in the system was industrial
R&D.[131] This
was attributed to short-termism in the private sector, as companies
were "looking to offload costs on to the university sector
and looking for incredibly short buyback periods for paybacks".[132]
Professor Alan Hughes, Director of the Innovation Research Centre
at the University of Cambridge, explained that R&D work in
the private sector:
[
] is fantastically concentrated in the
hands of a small number of firms. The strategic decisions by those
firms are absolutely critical to the matching of any public sector
R&D. [
] The whole of the independent SME sector in the
UK accounts for less than 4% of our R&D effort. There is a
real order of magnitude problem in thinking that SMEs are going
to do something dramatic. The other aspect is the internationalisation
of our largest R&D spenders. It is not as if they are reducing
their R&D expenditures, but the proportion that UK-based multinationals
are investing in overseas R&D has risen relative to their
domestic R&D.[133]
66. Professor Hughes also told us that there was
clear evidence that the UK's "excellence in scientific research
crowds in resources from the private sector", meaning that
"if you spend on public sector R&D [
] the willingness
of the private sector to pay is high".[134]
Increasing public investment in R&D can therefore drive virtuous
circles of private investment and innovation "as quality
of research attracts international talent, which in turn attracts
global companies-all of which results in further advances in both
new knowledge and exploitation".[135]
This was confirmed by the Government's recent analysis of the
effect of public sector support for innovation, which stated that:
Direct public investment in R&D to support
innovation leverages extra investment from the private sector.
Each £1 of public investment in collaborative R&D is
estimated to offer a [
] return of £6.71 before taking
spillover effects into account. Direct public investment in R&D
also leads to a long run increase in firms' absorptive capacity.[136]
67. The EU's Europe 2020 "growth strategy for
the coming decade" sets a 3% objective for R&D intensity,
which is translated into national targets in many EU countries.[137]
The UK has not adopted this target.[138]
However, the Secretary of State for Business, Innovation and Skills
has described 2.9% of GDP as "the indicative level necessary
for the UK's future economic success".[139]
68. We recommend that the Government aims for
3 per cent of GDP to be spent on R&D by 2020. This aim should
be built into the Science and Innovation Strategy as a long-term
objective and as an indication of the UK's commitment to building
capability in this area.
Stability in the innovation ecosystem
69. The importance of stability in the system of
support for innovation was a reoccurring theme in evidence to
the inquiry. We heard that stability and continuity were "essential"
to allow universities and industry "to build up knowledge
and experience of the schemes".[140]
Instead of "endless"[141]
new schemes being invented, we heard that businesses "crave"[142]
continuity. Indeed, John Latham, Vice Chancellor of Coventry University,
attributed the relative success of Germany's innovation system
to the "longevity, flexibility and stability" of its
initiatives.[143]
70. This has also been recognised by the Government's
own analysis of the UK innovation system, which reported a perception
amongst businesses that the UK "tends to make frustratingly
frequent changes" to innovation support mechanisms.[144]
The Minister acknowledged that stability of initiatives was important,
stating:
There is a great temptation for Ministers to
come up with a new scheme, get a new name and a new logo, launch
it and have a celebratory lunch to congratulate all concerned.
It may be enjoyable, but a logo, a launch and a lunch is not the
way that I would proceed.[145]
71. We agree with the Minister that greater stability
in the innovation support system is required. We expect the forthcoming
Innovation Strategy to deliver on the desire from businesses and
universities for a long-term commitment to, and increasing stability
of, mechanisms to support innovation and business-university collaboration.
114 BIS, Insights from international benchmarking of the UK science and innovation system,
January 2014, p7 Back
115
BIS, Insights from international benchmarking of the UK science and innovation system,
January 2014, para 114 Back
116
BIS, Insights from international benchmarking of the UK science and innovation system,
January 2014, para 134 Back
117
Science and Technology Committee, Eighth Report of Session 2012-13,
Bridging the valley of death: improving the commercialisation of research,
HC 348. Back
118
Q370 [Greg Clark] Back
119
Q372 [Greg Clark] Back
120
Q374 [Greg Clark] Back
121
National Audit Office, Research and Development funding for science and technology in the UK,
June 2013 Back
122
BIS, Insights from international benchmarking of the UK science and innovation system,
January 2014, para 4 Back
123
Sheffield Political Economy Research Institute, The UK's innovation deficit and how to repair it,
October 2013, p2 Back
124
Sheffield Political Economy Research Institute, The UK's innovation deficit and how to repair it,
October 2013, p3 Back
125
HoC Library, Standard Note SN/SG/6967. 2014 Back
126
European Commission, Innovation Union Scoreboard 2010, 2011 Back
127
European Commission, Innovation Union Scoreboard 2014, 2014 Back
128
Figure 3 taken from Sheffield Political Economy Research Institute,
The UK's innovation deficit and how to repair it, October 2013 Back
129
CaSE, Policy briefing: Science and Engineering Investment, p2 Back
130
Q2 [Will Hutton] Back
131
Q158 [Professor Jones] Back
132
Q11 [Will Hutton] Back
133
Q4 [Professor Hughes] Back
134
Q10 [Professor Hughes] Back
135
BIS, Insights from international benchmarking of the UK science and innovation system,
January 2014, p30 Back
136
BIS, Estimating the effect of UK direct public support for innovation,
2014, p19 Back
137
European Commission, Europe 2020 targets: research and development,
accessed November 2014 Back
138
National Audit Office, Research and Development funding for science and technology in the UK,
June 2013, p37 Back
139
Speech by the Secretary of State, 22 July 2014 Back
140
The Institute of Cancer Research (BUF61) Back
141
Q14 [Alan Hughes] Back
142
Q202 [Dr Hutchins] Back
143
Q184 [John Latham] Back
144
BIS, Insights from international benchmarking of the UK science and innovation system,
January 2014, para 116 Back
145
Q380 [Greg Clark] Back
|